Targeting the Synthetic Vulnerability of <i>PTEN</i> -Deficient Glioblastoma Cells with MCL1 Inhibitors
Chao Chen(Shanghai University), Fan Lin(Utrecht University), Lukui Chen(Qingdao University), Jie Yan(Central South University), Sichao Zhu(Nanjing Medical University), Yezi Chai(Nanjing Medical University), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Tingting Zhou(Nanjing Medical University), Jing Gu(Dalian Ocean University), Yurong Xu(Nanjing Medical University), Yunfen Hua(Zhejiang University of Science and Technology), Xiao Qi(Nanjing Medical University), Xia Zhang(Nanjing University of Chinese Medicine), Quan Wan(Nanjing Medical University)
Cited by 20
Related Papers
Coronavirus disease 2019 in pregnant women: a report based on 116 cases
|American Journal of Obstetrics and Gynecology|2020|699
GWASdb: a database for human genetic variants identified by genome-wide association studies
|Nucleic Acids Research|2011|233
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
|Clinical Cancer Research|2014|147
CAUSALdb: a database for disease/trait causal variants identified using summary statistics of genome-wide association studies
|Nucleic Acids Research|2019|84
Porcine deltacoronavirus nsp15 antagonizes interferon-β production independently of its endoribonuclease activity
|Molecular Immunology|2019|83